A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
The purpose of this study is to collect medical information about HIV-positive pregnant women
 and their babies who have been (or are being) seen at study sites. This information will be
 used to help design future research studies for these patients.

 The population of HIV-positive pregnant women and their babies who are seen at study sites
 has not been officially examined. In order to design future studies to research the best care
 for these patients, this study will examine important characteristics and the general number
 of women in these trials.
The population served at affiliated ACTG sites has not been officially described. Anecdotal
 evidence, however, has surfaced regarding the characteristics of HIV-infected pregnant women
 and the current standard of care during pregnancy. This chart abstraction study is designed
 to define, more accurately, the pertinent characteristics and general numbers of women in
 these trials.

 In this medical chart abstraction study, pertinent information is collected on all
 HIV-infected pregnant women and their infants who receive primary or consultative care at
 PACTG 367 study sites. Part A profiles all HIV-infected women who received care or
 consultation at study sites and who had a pregnancy outcome between January 1, 1998 through
 July 1, 1998. [AS PER AMENDMENT 04/12/02: Part A is closed to enrollment.] Part B profiles
 HIV-infected pregnant women who receive primary or consultative care and a pregnancy outcome
 following July 1, 1998.
Inclusion Criteria

 A patient may be eligible for this study if she:

 -  Is an HIV-positive woman.

 -  Is receiving care at a study site during the study period or her infant is receiving
 care at a study site and whose delivery information is available.

 -  Had a baby on or after January 1, 1998.